Evidence map›Paper›PMID 18315872›Full record

ArticleBMC genomics2008

Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes.

Garrett Sorensen, Sarah Medina, Debra Parchaliuk, Clark Phillipson, Catherine Robertson, Stephanie A Booth

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Mechanisms of prion-induced toxicity.Cell and tissue research · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. RNA editing alterations define manifestation of prion diseases.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Garrett SorensenPrion Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, R3E 3R2, Canada. Garrett_Sorensen@phac-aspc.gc.ca
Sarah Medina
Debra Parchaliuk
Clark Phillipson
Catherine Robertson
Stephanie A Booth
Public Health Agency of Canada · CA

Funding

DEVELOPMENT OF ASSAY FOR CREUTZFELDT-JAKOB DISEASE-265002327N01NS002327 · NINDS · BALTIMORE RESEARCH &EDUC FDN · 2002 to 2002
–
NINDS NIH HHS N01-NS-0-2327
6 · The paper itself

Abstract

backgroundPrion infection results in progressive neurodegeneration of the central nervous system invariably resulting in death. The pathological effects of prion diseases in the brain are morphologically well defined, such as gliosis, vacuolation, and the accumulation of disease-specific protease-resistant prion protein (PrPSc). However, the underlying molecular events that lead to the death of neurons are poorly characterised.

resultsIn this study cDNA microarrays were used to profile gene expression changes in the brains of two different strains of mice infected with three strains of mouse-adapted scrapie. Extensive data was collected and analyzed, from which we identified a core group of 349 prion-related genes (PRGs) that consistently showed altered expression in mouse models. Gene ontology analysis assigned many of the up-regulated genes to functional groups associated with one of the primary neuropathological features of prion diseases, astrocytosis and gliosis; protein synthesis, inflammation, cell proliferation and lipid metabolism. Using a computational tool, Ingenuity Pathway Analysis (IPA), we were able to build networks of interacting genes from the PRG list. The regulatory cytokine TGFB1, involved in modulating the inflammatory response, was identified as the outstanding interaction partner for many of the PRGs. The majority of genes expressed in neurons were down-regulated; a number of these were involved in regulatory pathways including synapse function, calcium signalling, long-term potentiation and ERK/MAPK signalling. Two down-regulated genes coding for the transcription regulators, EGR1 and CREB1, were also identified as central to interacting networks of genes; these factors are often used as markers of neuronal activity and their deregulation could be key to loss of neuronal function.

conclusionThese data provides a comprehensive list of genes that are consistently differentially expressed in multiple scrapie infected mouse models. Building networks of interactions between these genes provides a means to understand the complex interplay in the brain during neurodegeneration. Resolving the key regulatory and signaling events that underlie prion pathogenesis will provide targets for the design of novel therapies and the elucidation of biomarkers.

Indexed as

Gene Regulatory NetworksTranscription, GeneticAnimalsCyclic AMP Response Element-Binding ProteinDisease Models, AnimalDown-RegulationEarly Growth Response Protein 1Gene Expression ProfilingMiceMice, Inbred C57BLMitogen-Activated Protein Kinase KinasesPrion DiseasesPrionsProtein Array AnalysisCreb1 protein, mouseCyclic AMP Response Element-Binding ProteinEarly Growth Response Protein 1Egr1 protein, mouseMitogen-Activated Protein Kinase KinasesPrions

Identifiers

PMID18315872
PMCPMC2294129
OpenAlexW2063139737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.